Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5
Chai Phei Gan, Sau Yee Kok, Bernard Kok Bang Lee, Natasha Zulaziz, Sok Ching Cheong, Natalia Savelyeva, Kue Peng Lim · 2025
Read Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5 by Chai Phei Gan, Sau Yee Kok, Bernard Kok Bang Lee, Natasha Zulaziz, Sok Ching Cheong, Natalia Savelyeva, Kue Peng Lim (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12728998.txt.
Description
Chai Phei Gan and six co-authors published a cancer immunology study in twenty twenty-five on waking the immune system to nasopharyngeal carcinoma. The tumor is considered immune-hot, yet most cases switch off the machinery that displays antigens, hiding from T cells. The team tested whether a cancer vaccine could switch the display back on.
Profiling forty-two tumors against a seventeen-gene presentation signature singled out NLRC5 as the most silenced gene; it is the master regulator of the display molecule MHC-I. Vaccine-trained T cells restored presentation genes in tumor cells. In a mouse model chosen for poor immunogenicity, the vaccine modulated the same pathway. The work suggests vaccines can do more than aim immunity; they can unmask the target.
Catalog record
| CREATOR | Chai Phei Gan, Sau Yee Kok, Bernard Kok Bang Lee, Natasha Zulaziz, Sok Ching Cheong, Natalia Savelyeva, Kue Peng Lim |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |